KDIGO 2021 Blood Pressure Target Update and Chronic Kidney Disease Progression
Sriwijaya Journal of Internal Medicine · 2023
DOI: 10.59345/sjim.v1i2.78 ↗Kurz gefasst
Fachartikel in der Zeitschrift Sriwijaya Journal of Internal Medicine, 2023. Verfasst von Guo Jifei und 1 weiteren Autor:innen.
Abstract (Originalsprache)
In 2021, Kidney Disease: Improving Global Outcomes (KDIGO) published revised guidelines, including updated recommendations for the management of chronic renal disease and the control of blood pressure. The 2021 KDIGO Guidelines utilize current research and comprehensive scientific evidence to provide the most favorable blood pressure goals for those suffering from chronic kidney disease. The primary objective is to decelerate the advancement of renal impairment, mitigate problems linked to chronic kidney disease, and enhance the patient's quality of life. The 2021 KDIGO guidelines ground the blood pressure target recommendations for patients with chronic kidney disease (CKD) in a thorough evaluation of the extent of kidney damage, cardiovascular risk, and individual patient characteristics. The 2021 KDIGO guidelines recommend tailoring blood pressure control in patients with CKD to each individual rather than following a standardized method.
Zitieren
APA
Jifei, G., & Yinliang, X. (2023). KDIGO 2021 Blood Pressure Target Update and Chronic Kidney Disease Progression. Sriwijaya Journal of Internal Medicine. https://doi.org/10.59345/sjim.v1i2.78
Vancouver
Jifei G, Yinliang X. KDIGO 2021 Blood Pressure Target Update and Chronic Kidney Disease Progression. Sriwijaya Journal of Internal Medicine. 2023. doi:10.59345/sjim.v1i2.78
BibTeX
@article{Jifei2023,
author = {Jifei, Guo and Yinliang, Xi},
title = {KDIGO 2021 Blood Pressure Target Update and Chronic Kidney Disease Progression},
journal = {Sriwijaya Journal of Internal Medicine},
year = {2023},
doi = {10.59345/sjim.v1i2.78}
}
EUVIMED